Literature DB >> 26774019

Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.

L Monnier1, C Colette2.   

Abstract

Both postprandial and fasting (basal) hyperglycaemia contribute to overall hyperglycaemia (ambient hyperglycaemia) in type 2 diabetes (T2D). Postprandial glucose is the main contributor in fairly well controlled individuals, whereas basal hyperglycaemia becomes the preponderant contributor in poorly controlled patients. A more generally acceptable description of the contribution of postprandial glucose is to simply say that the absolute impact of postprandial glucose to HbA1c remains constant at approximately 1% across the entire HbA1c spectrum of non-insulin-treated patients with T2D. While epidemiological and pathophysiological studies seem to indicate that excessive postprandial glucose excursions play a role in or are predictors of cardiovascular diseases, there is still currently a lack of clinical evidence that correcting post-meal hyperglycaemia can improve clinical outcomes. However, even in the absence of consensus, there are many reasons for thinking that excessive postprandial glucose might be an independent risk factor for diabetic complications as it contributes to both overall glucose exposure and glycaemic variability, especially in those who have HbA1c levels < 7.5-8%. Given that excessive glucose fluctuations from peaks to nadirs activate oxidative stress, it seems reasonable to consider that a key player in the pathogenesis of diabetic complications, according to the latest IDF guidelines, is post-meal glucose, thereby warranting its assessment and treatment when found at abnormally elevated levels. Nevertheless, healthcare professionals should bear in mind that targeting both post-meal and basal plasma glucose, giving equal consideration to both of them, is probably the best strategy for achieving optimal glycaemic control and thus preventing or reducing the risk of diabetic complications.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Basal glucose; Diabetic complications; Overall glucose exposure; Postprandial glucose; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26774019     DOI: 10.1016/S1262-3636(16)30003-9

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  21 in total

1.  Restricting carbohydrates at breakfast is sufficient to reduce 24-hour exposure to postprandial hyperglycemia and improve glycemic variability.

Authors:  Courtney R Chang; Monique E Francois; Jonathan P Little
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

2.  Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis.

Authors:  Michelle C Flynn; Michael J Kraakman; Christos Tikellis; Man K S Lee; Nordin M J Hanssen; Helene L Kammoun; Raelene J Pickering; Dragana Dragoljevic; Annas Al-Sharea; Tessa J Barrett; Fiona Hortle; Frances L Byrne; Ellen Olzomer; Domenica A McCarthy; Casper G Schalkwijk; Josephine M Forbes; Kyle Hoehn; Liza Makowski; Graeme I Lancaster; Assam El-Osta; Edward A Fisher; Ira J Goldberg; Mark E Cooper; Prabhakara R Nagareddy; Merlin C Thomas; Andrew J Murphy
Journal:  Circ Res       Date:  2020-06-22       Impact factor: 17.367

3.  Effect of Different Nutritional Supplements on Glucose Response of Complete Meals in Two Crossover Studies.

Authors:  Nele Gheldof; Celia Francey; Andreas Rytz; Léonie Egli; Frederik Delodder; Lionel Bovetto; Nathalie Piccardi; Christian Darimont
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

Review 4.  FGF1 - a new weapon to control type 2 diabetes mellitus.

Authors:  Emanuel Gasser; Christopher P Moutos; Michael Downes; Ronald M Evans
Journal:  Nat Rev Endocrinol       Date:  2017-06-30       Impact factor: 43.330

5.  Glycaemic potency reduction by coarse grain structure in breads is largely eliminated during normal ingestion.

Authors:  Akila Srv; Suman Mishra; Allan Hardacre; Lara Matia-Merino; Kelvin Goh; Frederick J Warren; John Alexander Monro
Journal:  Br J Nutr       Date:  2021-07-05       Impact factor: 4.125

6.  The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.

Authors:  Jian-Bin Su; Xiao-Hua Yang; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Li-Hua Zhao; Feng Xu; Tong Chen; Xing-Bo Cheng; Xue-Qin Wang; Yan Lu
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

7.  HbA1c Cutoff for Prediabetes and Diabetes Based on Oral Glucose Tolerance Test in Obese Children and Adolescents.

Authors:  Hyo Kyoung Nam; Won Kyoung Cho; Jae Hyun Kim; Young Jun Rhie; Sochung Chung; Kee Hyoung Lee; Byung Kyu Suh
Journal:  J Korean Med Sci       Date:  2018-03-19       Impact factor: 5.354

8.  Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.

Authors:  Chen-Yi Yang; Pei-Fang Su; Jo-Ying Hung; Huang-Tz Ou; Shihchen Kuo
Journal:  Cardiovasc Diabetol       Date:  2020-07-06       Impact factor: 9.951

Review 9.  Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus.

Authors:  Rajeev Chawla; Jagat Jyoti Mukherjee; Manoj Chawla; Alok Kanungo; Meenakshi Sundaram Shunmugavelu; Ashok Kumar Das
Journal:  Med Sci (Basel)       Date:  2021-05-28

10.  Glucose-lowering effect of whey protein depends upon clinical characteristics of patients with type 2 diabetes.

Authors:  Rogelio U Almario; Wendy M Buchan; David M Rocke; Sidika E Karakas
Journal:  BMJ Open Diabetes Res Care       Date:  2017-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.